CLRB - Cellectar Biosciences stock slumps 35% PM prices public offering and private placement

Cellectar Biosciences (CLRB) prices previously announced underwritten public offering of its common stock for gross proceeds of ~$24.5M at a public offering price of $1.35 per share.In a separate concurrent private placement transaction led by healthcare-focused institutional investors, company offered and sold 1,518.5180 shares of convertible preferred stock for gross proceeds of ~$20.5M.The public offering and the private placement are expected to close on or about December 28, 2020.Shares slumps 35% during pre-market hours.Previously: Cellectar Bio readies stock offering (Dec. 23)

For further details see:

Cellectar Biosciences stock slumps 35% PM, prices public offering and private placement